U.S. Chemicals Stock News

In the past few days, Phillips 66 reported that second-quarter adjusted earnings rose by almost triple year over year as refining margins roughly doubled amid wartime supply disruptions and tight global refining capacity, while the company advanced projects like the Western Gateway pipeline and continued paying down debt and returning cash to shareholders. An interesting angle is that Western Gateway’s primarily 10-year take-or-pay contracts are intended to lock in more predictable midstream...

Why Air Products and Chemicals Stock Is Back in Focus Sustained analyst optimism after recent positive earnings has put Air Products and Chemicals (APD) back on many investors’ watchlists, even as high capital spending, project exit charges, and helium pricing pressure remain front and center. See our latest analysis for Air Products and Chemicals. After a stronger run year to date, with a 21.1% share price return and a last close of $303.22, Air Products and Chemicals’ move has been more...

How IDACORP Stock Has Been Performing IDACORP (IDA) has drawn investor attention after recent trading left the stock about 4% lower over the past month, while total return over the past year remains about 14%. See our latest analysis for IDACORP. At a latest share price of US$140.76, IDACORP has seen recent momentum cool, with the 30-day share price return down 4.3%, even as the 1-year total shareholder return sits at about 14%. This points to a stock where long-term holders have still been...

Tempus AI (TEM) stock is in focus after CellCarta Inc. added the company as the second commercial laboratory partner in its CDx Commercialization Lab Network for oncology companion diagnostics. See our latest analysis for Tempus AI. The CellCarta agreement has arrived alongside a sharp shift in momentum for Tempus AI, with the share price up 24.09% over the last day and a 30 day share price return of 26.52%, yet the 1 year total shareholder return has declined 16.42%. This suggests that...

Canadian Solar (NasdaqGS:CSIQ) is back in focus after a key legal overhang was removed. A long running U.S. patent infringement dispute with Maxeon Solar has now been resolved fully in Canadian Solar's favor. See our latest analysis for Canadian Solar. The legal win arrives as Canadian Solar's share price reacts sharply in the short term, with a 1 day share price return of 7.06% and a 30 day share price return of 3.82%, while the year to date share price return is down 37.90% and the 3 year...

Pfizer (NYSE:PFE) has reached a settlement program intended to resolve a major portion of federal Depo-Provera intracranial meningioma lawsuits. The program targets a substantial share of more than 6,200 pending cases, with estimates that around 5,000 claims could be resolved under the agreement. The settlement is a potentially material legal development that may influence Pfizer’s litigation reserves, risk profile, and public perception. For a broader view of how large pharmaceutical and...

Acadia Realty Trust (AKR) drew investor attention after extending a US$75 million loan to BTF Whitestone LLC to acquire and redevelop the Whitestone Shopping Center in Queens, a grocery anchored retail property. See our latest analysis for Acadia Realty Trust. Over the past year, Acadia Realty Trust has combined relatively muted recent share price moves with stronger longer term outcomes, with a 1 year total shareholder return of 14.18% and a 3 year total shareholder return of 66.73%. The...

In recent months, Crown Castle has been contending with a higher-for-longer interest rate backdrop while restructuring its balance sheet and reducing debt, even as a bankruptcy claim tied to tenant DISH Wireless introduces additional uncertainty. This combination of financing pressures and customer-related legal risk directly affects how secure Crown Castle’s cash flows may appear to investors and lenders. Next, we’ll examine how the interest rate pressure and DISH-related bankruptcy...

Earlier this month, Eli Lilly and Company committed to deploy Veeva Vault CRM globally as part of Veeva’s Vault CRM Suite supporting agentic commercial workflows. This global rollout by a major pharmaceutical company highlights growing interest in AI-enabled commercial tools like Veeva’s Agentic Call Report to help generate commercial evidence. We’ll now examine how Eli Lilly’s global Vault CRM commitment could influence Veeva’s investment narrative, especially around AI‑driven commercial...

Axon Enterprise has delivered a very strong 246.4% return over the past 5 years, yet the latest valuation checks suggest the stock may now be pricing in a lot of optimism. The Discounted Cash Flow (DCF) intrinsic value estimate points to a premium to current fundamentals, while market based multiples look roughly in line with peers and the broader checks lean expensive. Over the past 5 years, Axon Enterprise has returned 246.4%, which puts long term holders in a strong position and raises...

KBR recently announced that its Mission Technology Solutions business, set to become Trinzic after a planned spin-off, secured new multi-year NATO and U.S. Army contracts worth up to about US$268 million alongside a regular US$0.165 quarterly dividend, while Kellogg Brown & Root LLC was chosen for a USTDA-backed green ammonia Pre-FEED project in Morocco. Together, these defense awards and low-carbon ammonia design work highlight how KBR’s mission-tech spin-off and technology licensing...

AbCellera Biologics (ABCL) drew fresh attention after reporting that its investigational antibody ABCL635 met primary efficacy endpoints in a Phase 2 trial for menopausal vasomotor symptoms, with statistically significant benefits versus placebo. See our latest analysis for AbCellera Biologics. Alongside the ABCL635 data, AbCellera Biologics has attracted fresh attention, with a 30 day share price return of 107.07% and a year to date share price return of 250.15%. The 1 year total shareholder...

With U.S. government debt now above $40b and Treasury yields at levels last seen before the global financial crisis, the cost of money is back in the spotlight. That shift can reshape which stocks benefit from higher rates and which feel pressure on valuations. This article looks at three stocks from a higher rate focused screener that appear particularly exposed to this move in markets and explains what that could mean for your portfolio. The stocks highlighted below are just a starting...

With the Fed minutes hinting that another rate hike is still on the table and inflation data hovering above the 2% target, short term cash and bond products linked to these decisions are back in the spotlight. This creates potential openings for investors watching short duration yields and money markets. This article first unpacks the backdrop, then walks through three stocks from our U.S. short duration and cash focused screener that appear positively exposed to this news. The stocks covered...

Exponent (EXPO) has caught investor attention after its recent share price move, with the stock up 3.6% over the past week and about 11.5% over the past month based on provided data. See our latest analysis for Exponent. Zooming out, Exponent’s recent 90 day share price return of 22.52% contrasts with a year to date share price move that is roughly flat. The 3 year and 5 year total shareholder returns show declines, which suggests momentum has picked up only in the shorter term as investors...

Masco Corporation recently announced that its Board of Directors declared a quarterly dividend of US$0.32 per common share, paid on August 28, 2026, to shareholders of record on August 24, 2026. This dividend affirmation comes as Masco reports consecutive earnings beats and a higher full-year adjusted EPS outlook, helped by tariff refunds and restructuring efficiencies. Next, we’ll examine how Masco’s upgraded full-year adjusted EPS guidance reshapes its existing investment narrative and...

Green Plains earnings and production update Green Plains (GPRE) recently reported second quarter 2026 results that combined lower sales of US$446.22 million with a move to net income of US$67.15 million from a loss a year earlier. At the same time, the company released unaudited operating data that showed reduced ethanol, distillers grains, ultra high protein and renewable corn oil output compared with the prior year period, along with lower corn consumption. See our latest analysis for Green...

Shoals Technologies Group (SHLS) drew fresh attention after announcing that manufacturing and deliveries are underway for a 1.1 GW hyperscale data center battery project with ON.energy, described as the largest planned grid connected installation in the United States. See our latest analysis for Shoals Technologies Group. Against this backdrop, Shoals Technologies Group has seen its 1 year total shareholder return of 29.27% contrast with a year to date share price return down 12.54%. Recent...

Dividend increase draws attention to Carlisle Companies stock Carlisle Companies (CSL) has drawn investor focus after its board approved a 14% increase in the regular quarterly dividend to $1.25 per share, payable on September 1, 2026. See our latest analysis for Carlisle Companies. Carlisle Companies’ dividend move comes after a period where the share price has shown positive momentum in recent months, with an 11.7% 1 month share price return and a 10.0% 3 month share price return, while the...

Vistance Networks, Inc. reported past second-quarter 2026 results with sales of US$319.6 million versus US$324.1 million a year earlier, but net income rose sharply to US$295.2 million from US$31.8 million, and the Board also declared a US$5.00 per share special cash distribution payable in August 2026. While revenue changed only slightly, the very large increase in earnings per share, alongside the special distribution, highlights significant shifts in profitability and capital...

Earlier this month, Mercury Insurance launched an enhanced homeowners insurance product in Oklahoma, adding new discounts for hail-resistant roofs, FORTIFIED homes, wildfire mitigation, and optional coverage upgrades tailored to severe-weather risks. The product’s combination of upfront premium reductions and post-loss upgrade options uniquely encourages policyholders to harden their homes against future storms and wildfires. We’ll now examine how this expanded Oklahoma homeowners offering,...

In recent days, Eli Lilly announced multiple R&D agreements, including global rights to AlzeCure’s preclinical Alzheimer’s candidate ACD680 with potential milestones above US$1.00 billion, an ion channel collaboration with OmniAb, and a taRNA vaccine partnership with Amplitude Therapeutics, while also securing UK approval of its once-daily oral GLP‑1 drug Foundayo for weight management and type 2 diabetes. These deals and the Foundayo approval deepen Lilly’s presence in obesity,...

Progressive stock has delivered a very strong 152.4% return over the past 5 years. On current checks it now looks closer to fairly priced than clearly cheap or clearly expensive. For investors, the question is how to read that long term gain against valuation signals that point to an “about right” market view. Progressive has returned 152.4% over 5 years, which puts long term holders in a strong position and raises the bar for any further value driven upside. Future underwriting discipline...

Millicom International Cellular (TIGO) has declared an interim dividend of $1.50 per share, to be paid in two $0.75 U.S. dollar installments in early 2027, following what the company describes as strong financial performance. See our latest analysis for Millicom International Cellular. Millicom International Cellular's recent dividend decision comes after a strong run in the stock, with the latest share price at US$88.75, a year to date share price return of 56.94% and a 1 year total...